Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

59,448 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

59,448 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

59,448 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

59,448 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
59,448 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
59,448 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

59,448 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Jan 2026
Michael Wayne Domino Jr. President, DTR Division
Sold on a plan
$99.98K 24,996 at 4.00
1.7%
Planned (10b5-1)
21 Jan 2026
Steven Yi See Remarks
Sold on a plan
$88.18K 8,000 at 11.02
0.3%
Planned (10b5-1)
21 Jan 2026
Eric Richard Remer Chief Executive Officer
Sold on a plan
$82.80K 6,776 at 12.22
0.2%
Planned (10b5-1)
21 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$79.67K 339 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Casey O'Connor Chief Legal Officer
Sold on a plan
$73.97K 13,852 at 5.34
2.5%
Planned (10b5-1)
21 Jan 2026
Eugene Nonko Director · indirect
Sold on a plan
$73.82K 6,700 at 11.02
0.4%
Planned (10b5-1)
21 Jan 2026
Kenneth Robert Bertram CLO & Secretary
Sold at will
$72.40K 1,074 at 67.41
2.1%
Not planned
21 Jan 2026
Mark Alvino Director
Sold at will
$70.57K 13,500 at 5.23
21.7%
Not planned
21 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$68.86K 293 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Janet Dillione Director
Sold on a plan
$68.80K 10,000 at 6.88
20.6%
Planned (10b5-1)
21 Jan 2026
Theodoros Xenohristos Chief Concept Officer
Sold at will
$65.05K 965 at 67.41
0.3%
Not planned
21 Jan 2026
John Alexander Kelly Chief Financial Officer
Sold on a plan
$61.31K 15,213 at 4.03
12.5%
Planned (10b5-1)
21 Jan 2026
Chidozie Ugwumba 10% owner · indirect
Sold at will
$61.20K 12,119 at 5.05
1.9%
Not planned
21 Jan 2026
Christopher Vanderhook Chief Operating Officer · indirect also filed by Timothy Vanderhook
Sold on a plan
$60.30K 4,926 at 12.24
65.7%
Sold half or more
21 Jan 2026
Eugene Nonko Director
Sold on a plan
$59.51K 5,400 at 11.02
0.6%
Planned (10b5-1)
21 Jan 2026
Randall K Fields Chief Executive Officer · indirect
Sold on a plan
$54.55K 5,000 at 10.91
3.5%
Planned (10b5-1)
21 Jan 2026
Jay S Stout Chief Technology Officer
Sold at will
$51.46K 1,977 at 26.03
1.0%
Not planned
21 Jan 2026
Shawn Tomasello Director · indirect
Bought
$50.32K 22,725 at 2.21
opened
First buy on file
21 Jan 2026
Steve Gavel Chief Commercial Officer
Bought
$50.22K 22,170 at 2.27
opened
First buy on file
21 Jan 2026
Sold at will
$48.66K 1,896 at 25.67
100%
Sold half or more
21 Jan 2026
Ned S Holmes Director · indirect
Sold on a plan 4×
$44.57K 600 at 74.29
1.4%
Planned (10b5-1)
21 Jan 2026
J. Jefferson Smith Chief Research Officer
Sold on a plan
$41.11K 10,200 at 4.03
8.5%
Planned (10b5-1)
21 Jan 2026
Zachary Roberts EVP of R&D
Sold at will
$40.98K 26,269 at 1.56
4.1%
Not planned
21 Jan 2026
Paul V Walsh Jr Director
Sold on a plan
$39.13K 500 at 78.25
1.9%
Planned (10b5-1)
21 Jan 2026
Ned S Holmes Director
Sold on a plan 2×
$37.14K 500 at 74.29
0.6%
Planned (10b5-1)
21 Jan 2026
Dario Scimeca General Counsel and Secretary
Sold on a plan
$35.68K 8,854 at 4.03
16.5%
Planned (10b5-1)
21 Jan 2026
Edward J. Lehner President & CEO
Sold on a plan
$30.01K 1,000 at 30.01
0.2%
Planned (10b5-1)
21 Jan 2026
Shane Thomas Gleason Chief Commercial Officer
Sold at will
$28.55K 17,593 at 1.62
1.5%
Not planned
21 Jan 2026
Brian Cree President
Sold on a plan
$28.36K 1,440 at 19.69
0.3%
Planned (10b5-1)
21 Jan 2026
John O Agwunobi Director
Sold on a plan
$26.03K 146 at 178.31
1.6%
Planned (10b5-1)
21 Jan 2026
Mark Simon Director
Bought
$25.26K 11,061 at 2.28
8.1%
First buy in 3+ yrs
21 Jan 2026
Gwendolyn Binder President, Science & Tech.
Bought
$24.76K 11,312 at 2.19
56.6%
First buy in 3+ yrs
21 Jan 2026
Peter Platzer Executive Chairman
Sold on a plan
$21.79K 1,801 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Sold on a plan
$20.50K 25,000 at 0.82
14.3%
Planned (10b5-1)
21 Jan 2026
Charles Peter Kirol Chief Operating Officer
Sold on a plan
$19.90K 3,399 at 5.85
4.2%
Planned (10b5-1)
21 Jan 2026
David J. Chang Chief Medical Officer
Bought
$19.89K 8,800 at 2.26
opened
First buy on file
21 Jan 2026
Daniel Joseph OConnell Chief Executive Officer
Sold at will
$16.93K 9,346 at 1.81
1.0%
Not planned
21 Jan 2026
Eagle Point Credit Management LLC 10% owner · indirect
Sold at will
$15.27K 692 at 22.07
0.1%
Not planned
21 Jan 2026
Michael Gerard General Counsel
Bought
$14.98K 6,600 at 2.27
opened
First buy on file
21 Jan 2026
Nicholas S Schorsch 10% owner · indirect
Bought
$14.70K 1,365 at 10.77
0.1%
21 Jan 2026
Theresa Condor Chief Executive Officer
Sold on a plan
$14.53K 1,201 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
David Sherry Chief Financial Officer
Sold on a plan 4×
$12.80K 145 at 88.26
0.0%
Planned (10b5-1)
21 Jan 2026
Saba Capital Management, L.P. 10% owner · indirect
Bought
$11.71K 550 at 21.29
0.0%
21 Jan 2026
Leslie Trigg Chair and CEO
Sold at will
$10.71K 2,120 at 5.05
2.0%
Not planned
21 Jan 2026
Sold at will
$10.24K 7,512 at 1.36
0.3%
Not planned
21 Jan 2026
Bought
$9.98K 4,405 at 2.27
441%
First buy in 3+ yrs
21 Jan 2026
Ramtin Agah Chief Medical Officer
Bought
$9.98K 10,000 at 1.00
1.3%
21 Jan 2026
Lei Wu Chief Executive Officer · indirect
Sold on a plan
$8.45K 210 at 40.26
0.0%
Planned (10b5-1)
21 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$6.00K 2,000 at 3.00
100%
Sold half or more
Showing 46,751–46,800 of 59,448. ← Newer Page 936 of 1,189 Older →